Compare BIO & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KBR |
|---|---|---|
| Founded | 1952 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 5.5B |
| IPO Year | N/A | 2006 |
| Metric | BIO | KBR |
|---|---|---|
| Price | $307.68 | $43.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $358.50 | $56.25 |
| AVG Volume (30 Days) | 158.4K | ★ 1.1M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 1.52% |
| EPS Growth | N/A | ★ 21.27 |
| EPS | N/A | ★ 2.89 |
| Revenue | $2,557,500,000.00 | ★ $8,041,000,000.00 |
| Revenue This Year | $1.77 | $2.43 |
| Revenue Next Year | $2.30 | $4.38 |
| P/E Ratio | ★ N/A | $13.69 |
| Revenue Growth | N/A | ★ 9.67 |
| 52 Week Low | $211.43 | $39.61 |
| 52 Week High | $373.69 | $60.98 |
| Indicator | BIO | KBR |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 54.59 |
| Support Level | $307.08 | $43.15 |
| Resistance Level | $319.50 | $44.52 |
| Average True Range (ATR) | 8.47 | 1.00 |
| MACD | -1.43 | 0.31 |
| Stochastic Oscillator | 6.82 | 68.62 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.